Herbalife Ltd.

As of October 31, 2025, Herbalife Ltd. shows a neutral technical trend with mixed signals, underperforming the S&P 500 recently but outperforming it year-to-date.

As of October 31, 2025, Herbalife Ltd. shows a neutral technical trend with mixed signals, underperforming the S&P 500 recently but outperforming it year-to-date.

As of October 31, 2025, Herbalife Ltd.'s technical trend has shifted to neutral with mixed signals, showing mild bearishness on the weekly MACD and bearish sentiment from Bollinger Bands, while underperforming the S&P 500 recently but outperforming it year-to-date, suggesting a cautious investment approach.

As of September 12, 2025, Herbalife Ltd. shows a bullish technical trend with mixed signals from indicators, outperforming the S&P 500 year-to-date and over the past year, but with negative long-term returns.

As of February 22, 2018, Herbalife Ltd. is considered a risky investment due to its overvaluation indicated by a low P/E ratio of 3 compared to peers, a less favorable EV to EBITDA ratio, and poor long-term performance despite a strong year-to-date return.

As of June 27, 2025, the trend is mildly bullish due to positive weekly MACD and daily moving averages, but mixed monthly indicators suggest caution.

As of February 22, 2018, Herbalife Ltd. is considered undervalued with a low P/E ratio of 3 and strong growth potential, despite a poor return of -26.92% over the past year compared to the S&P 500's 10.26%.

As of May 29, 2025, the market trend has shifted to mildly bearish, influenced by daily moving averages and monthly indicators, despite some bullish signals from the weekly MACD and Bollinger Bands.

As of March 2022, the management team of Herbalife Ltd. includes Independent Directors Dr. Richard Carmona, Alan LeFevre, Juan Mendoza, Michael Montelongo, and Maria Otero, who guide the company's governance and strategy.

Herbalife Ltd. is a global nutrition company that develops and sells nutritional products, classified as a micro-cap company with a market cap of approximately $882.47 million. As of March 2025, it reported net sales of $1.22 billion and a net profit of $50 million.

As of Jun 18, Herbalife Ltd. has a market capitalization of 882.47 million and reported net sales of 4,950.50 million and net profit of 280.40 million over the latest four quarters.